Palo Alto Networks Reported an Earnings Beat and Pfizer to Acquire Trillium Therapeutics

by 24 Aug, 2021

Palo Alto Reported an Earnings Beat and Trillium Therapeutics: Accepted a Buyout Offer

Palo Alto Networks

Palo Alto Networks is a technology company that focuses on cybersecurity. They are, in fact, located near Palo Alto, California, and they have a market cap of $36.285 billion, which classifies them as a large cap stock.

On Monday, Palo Alto Networks reported their quarterly earnings. They saw a beat on the key numbers, with their earnings per share being $1.60 and revenue being $1.22 billion. However, the unique part of this earnings report is that Palo Alto did not announce a new acquisition or merger, which has been the theme for the past couple of years. Nonetheless, Palo Alto Networks rose to $411.30 after hours, up 10.40%.  

Trillium Therapeutics

Trillium Therapeutics is a healthcare company that works in biotechnology. They are located in Toronto, Canada, and the business works on developing therapies for the treatment of cancer. Trillium has a market cap of $1.844 billion, making them a mid cap company.

That number is a bit different from the previous days as it was announced on Monday that pharmaceutical giant Pfizer would be acquiring the company in a $2.26 billion deal, which is around $18.50 per share. This decision was made as Pfizer believed that the company would be a big player in a breakthrough cancer treatment, and it was at a hefty premium. Trillium closed the day at $17.59, up 188.83%. 

I am not a financial advisor and my comments should never be taken as financial advice. Investments come with risk, so always do your research and analysis beforehand.

 

All emails include an unsubscribe link. You can opt-out at any time. ​See our privacy policy.

All emails include an unsubscribe link. You can opt-out at any time. ​See our privacy policy.

Invstr
(2K)
Get the app
Share This